These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 32731428)

  • 41. Vaccine development and therapeutic design for 2019-nCoV/SARS-CoV-2: Challenges and chances.
    Ghaebi M; Osali A; Valizadeh H; Roshangar L; Ahmadi M
    J Cell Physiol; 2020 Dec; 235(12):9098-9109. PubMed ID: 32557648
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The COVID-19 chemoprophylactic conundrum: Are we limiting available resources?
    Sharma A; Mhatre M; Goldust M; Jindal V; Singla P
    Dermatol Ther; 2020 Jul; 33(4):e13607. PubMed ID: 32418299
    [No Abstract]   [Full Text] [Related]  

  • 43. COVID-19: emerging protective measures.
    Balachandar V; Mahalaxmi I; Kaavya J; Vivekanandhan G; Ajithkumar S; Arul N; Singaravelu G; Senthil Kumar N; Mohana Dev S
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3422-3425. PubMed ID: 32271461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lockdown is an effective 'vaccine' against COVID-19: A message from India.
    Krishan K; Kanchan T
    J Infect Dev Ctries; 2020 Jun; 14(6):545-546. PubMed ID: 32683342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of Cloth Masks for Protection Against Severe Acute Respiratory Syndrome Coronavirus 2.
    Chughtai AA; Seale H; Macintyre CR
    Emerg Infect Dis; 2020 Oct; 26(10):. PubMed ID: 32639930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
    Ladoux A; Azoulay S; Dani C
    Med Sci (Paris); 2020; 36(6-7):555-558. PubMed ID: 32558640
    [No Abstract]   [Full Text] [Related]  

  • 47. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
    Fantini J; Chahinian H; Yahi N
    Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32405156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.
    Rabaan AA; Al-Ahmed SH; Sah R; Tiwari R; Yatoo MI; Patel SK; Pathak M; Malik YS; Dhama K; Singh KP; Bonilla-Aldana DK; Haque S; Martinez-Pulgarin DF; Rodriguez-Morales AJ; Leblebicioglu H
    Ann Clin Microbiol Antimicrob; 2020 Sep; 19(1):40. PubMed ID: 32878641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?
    Aricò E; Bracci L; Castiello L; Gessani S; Belardelli F
    Cytokine Growth Factor Rev; 2020 Aug; 54():43-50. PubMed ID: 32665127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19).
    Huang F; Li Y; Leung EL; Liu X; Liu K; Wang Q; Lan Y; Li X; Yu H; Cui L; Luo H; Luo L
    Pharmacol Res; 2020 Aug; 158():104929. PubMed ID: 32442720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coronavirus Disease 2019: Coronaviruses and Blood Safety.
    Chang L; Yan Y; Wang L
    Transfus Med Rev; 2020 Apr; 34(2):75-80. PubMed ID: 32107119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Very Long-acting Antivirals as Chemovaccines for Preventing Viral Infections.
    Soriano V; Barreiro P
    AIDS Rev; 2020 Jul; 22(2):124-127. PubMed ID: 32628223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanotechnology versus coronavirus.
    Nat Nanotechnol; 2020 Aug; 15(8):617. PubMed ID: 32764720
    [No Abstract]   [Full Text] [Related]  

  • 54. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
    Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
    In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of nanomaterials in treatment, anti-infection and detection of coronaviruses.
    Nikaeen G; Abbaszadeh S; Yousefinejad S
    Nanomedicine (Lond); 2020 Jun; 15(15):1501-1512. PubMed ID: 32378459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Face masks vs. COVID-19: a systematic review.
    Fouladi Dehaghi B; Ghodrati-Torbati A; Teimori G; Ibrahimi Ghavamabadi L; Jamshidnezhad A
    Invest Educ Enferm; 2020 Jul; 38(2):. PubMed ID: 33047556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms Underlying Potential Therapeutic Approaches for COVID-19.
    Benani A; Ben Mkaddem S
    Front Immunol; 2020; 11():1841. PubMed ID: 32793246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current development of COVID-19 diagnostics, vaccines and therapeutics.
    Zhang N; Li C; Hu Y; Li K; Liang J; Wang L; Du L; Jiang S
    Microbes Infect; 2020; 22(6-7):231-235. PubMed ID: 32387332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.
    Krishna G; Pillai VS; Veettil MV
    Eur J Pharmacol; 2020 Oct; 885():173450. PubMed ID: 32739174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?
    Sargin G; Yavaşoğlu Sİ; Yavasoglu I
    Med Hypotheses; 2020 Jul; 140():109756. PubMed ID: 32344306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.